Early stage biotech, Axcella Health, has filed for an $86 million IPO. The initial filing documents do not provide the number of shares in the offering or the expected price range. The company has... read more
MaaT Pharma announced on 4/9/19 that the independent Data and Safety Monitoring Board (DSMB) recommended the continuation, without amendment, of the ongoing Phase II HERACLES study (NCT03359980).... read more
On 4/8/19 researchers from Azitra, Inc., in collaboration withindependent, nonprofit biomedical research institutionThe Jackson Laboratory (JAX), announced they have demonstrated the feasibility... read more
OZ, a global consulting company enhancing customer experiences through digital innovation, recently launched a first-of-its-kind application that brings an augmented reality (AR) environment to... read more